USFDA visit in May/June 2017

  • Posted by: Biocon Biologics

Bengaluru, Karnataka, India, August 03, 2017:

The USFDA visit in May/June was a part of the regular periodic audits for a small molecule injectable. The company has responded to the regulator with a Corrective and Preventive Action Plan (CAPA) and is on track to implement them in a timely manner.

Please note Biocon has shared information related to this visit on July 31, 2017.

– Company Spokesperson

Author: Biocon Biologics